Search by Drug Name or NDC
NDC 70010-0054-05 butalbital and acetaminophen 300; 50 mg/1; mg/1 Details
butalbital and acetaminophen 300; 50 mg/1; mg/1
butalbital and acetaminophen is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Granules Pharmaceuticals Inc.. The primary component is ACETAMINOPHEN; BUTALBITAL.
Product Information
| NDC | 70010-0054 |
|---|---|
| Product ID | 70010-054_f4a2f8f9-7dc7-395b-e053-2995a90a6f00 |
| Associated GPIs | 64991002120105 |
| GCN Sequence Number | 078660 |
| GCN Sequence Number Description | butalbital/acetaminophen CAPSULE 50MG-300MG ORAL |
| HIC3 | H3K |
| HIC3 Description | ANALGESIC, NON-SALICYLATE AND BARBITURATE COMBINAT |
| GCN | 45029 |
| HICL Sequence Number | 001858 |
| HICL Sequence Number Description | BUTALBITAL/ACETAMINOPHEN |
| Brand/Generic | Generic |
| Proprietary Name | butalbital and acetaminophen |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | butalbital and acetaminophen |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 300; 50 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; BUTALBITAL |
| Labeler Name | Granules Pharmaceuticals Inc. |
| Pharmaceutical Class | Barbiturate [EPC], Barbiturates [CS] |
| DEA Schedule | CIII |
| Marketing Category | ANDA |
| Application Number | ANDA213115 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70010-0054-05 (70010005405)
| NDC Package Code | 70010-054-05 |
|---|---|
| Billing NDC | 70010005405 |
| Package | 500 CAPSULE in 1 BOTTLE (70010-054-05) |
| Marketing Start Date | 2020-01-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |